Bio-Techne Stock
StockStockPrice
Historical dividends and forecast
Bio-Techne has so far distributed $0.24 in 2024. The next dividend will be paid on 22.11.2024
CHART BY
Frequently asked questions
What is Bio-Techne's market capitalization?
What is Bio-Techne's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Bio-Techne?
What are the analyst ratings and target price for Bio-Techne's stock?
What is Bio-Techne's revenue over the trailing twelve months?
Is Bio-Techne paying dividends?
What is the EBITDA for Bio-Techne?
What is the free cash flow of Bio-Techne?
What is the 5-year beta of Bio-Techne's stock?
How many employees does Bio-Techne have, and what sector and industry does it belong to?
What is the free float of Bio-Techne's shares?
Financials
Market Cap
$11.82B5Y beta
1.27EPS (TTM)
$0.94Free Float
157.24MP/E ratio (TTM)
79.15Revenue (TTM)
$1.17BEBITDA (TTM)
$361.33MFree Cashflow (TTM)
$194.58MPricing
Analyst Ratings
The price target is $83.64 and the stock is covered by 12 analysts.
Buy
9
Hold
2
Sell
1
Information
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
3,100
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker